1,788 enforcement actions from 16 federal and state jurisdictions. Every event traced back to its official government source.
1,788
Total Actions
16
Jurisdictions
$51.8B+
Total Fines Tracked
The New York Attorney General issued guidance explaining Shield Law protections for reproductive and gender-affirming health care information and the steps required before responding to covered information requests. This is guidance, not an enforcement action against a named company; it describes potential penalties for improper disclosure or failure to follow required procedures.
New York Attorney General Letitia James and a coalition of 24 other states and the District of Columbia challenged a federal rule imposing additional proof requirements on some medically frail Medicaid recipients. The U.S. District Court for the District of Massachusetts granted summary judgment, declaring a central provision of the rule illegal and blocking it.
New York Attorney General Letitia James, the FTC, and six other state attorneys general asked a federal court to hold Martin Shkreli in contempt for allegedly trading pharmaceutical stocks and discussing pharmaceutical companies in violation of his lifetime industry ban. The requested sanctions include divestiture, an accounting of his trading, forfeiture of trading profits, and possible further fines or incarceration; the release describes a request to the court, not a new ruling imposing those measures.
New York Attorney General Letitia James joined a 15-state coalition in suing HHS Secretary Robert F. Kennedy, Jr., challenging changes that removed seven vaccines from the CDC’s list of vaccinations recommended for every child. The states allege the changes and ACIP appointments violated the Administrative Procedure Act and ask the court to invalidate them; the release reports no penalty or court-ordered remedy.
New York Attorney General Letitia James, joined by 27 other state attorneys general and the District of Columbia, filed a lawsuit against 23andMe to block the company’s planned sale of 15 million customers’ genetic and health data without their consent or knowledge. The coalition argues 23andMe must comply with state laws requiring express informed consent for the sale or transfer of sensitive genetic data. The lawsuit seeks to prevent misuse, exposure in future breaches, and unauthorized use of customers’ private genetic information.
All data sourced from official government enforcement pages.